STUB vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

STUB

39.2
AI Score
VS
GENI Wins

GENI

48.5
AI Score

Investment Advisor Scores

STUB

39score
Recommendation
AVOID NEW MONEY

GENI

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric STUB GENI Winner
Forward P/E 13.624 51.0204 STUB
PEG Ratio 0 0 Tie
Revenue Growth 33.2% 64.7% GENI
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.2/100 48.5/100 GENI
Profit Margin -91.3% -23.0% GENI
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD GENI

Relative Price Performance (Last 90 Days)

STUB 1M: +9.3% · 3M: -30.0% GENI 1M: +9.3% · 3M: -12.8%

Current Technical Phase

STUB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $5.89

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $6.34

Fundamentals Snapshot

Metric STUB GENI
Market Cap — —
Forward P/E 9.6 5.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.3% 0.6%
Gross Margin 0.8% 0.3%
Operating Margin 0.0% -0.1%
EPS -5.77 -0.67
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.